BACKGROUND: Previous research has provided evidence that
socioeconomic status has an impact on invasive treatments use after
acute myocardial infarction. In this paper, we compare the
socioeconomic inequality in the use of high-technology diagnosis and
treatment after acute myocardial infarction between the US, Quebec and
Belgium paying special attention to financial incentives and
regulations as explanatory factors.